Active, not recruitingPhase 2NCT06598462
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
Studying NON RARE IN EUROPE: Eosinophilic esophagitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Uniquity One (UNI)
- Principal Investigator
- Andrew W Lee, MDVice President, Clinical Research
- Intervention
- Solrikitug Low Dose(biological)
- Enrollment
- 184 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2024 – 2027
Study locations (30)
- Research Site 1039, Dothan, Alabama, United States
- Research Site 1018, Glendale, Arizona, United States
- Research Site 1018, Peoria, Arizona, United States
- Research Site 1037, Scottsdale, Arizona, United States
- Research Site 1003, Tucson, Arizona, United States
- Research Site 1023, Englewood, California, United States
- Research Site 1005, Irvine, California, United States
- Research Site 1015, San Diego, California, United States
- Research Site 1034, Aurora, Colorado, United States
- Research Site 1027, Cromwell, Connecticut, United States
- Research Site 1040, Inverness, Florida, United States
- Research Site 1001, Jacksonville, Florida, United States
- Research Site 1049, Miami, Florida, United States
- Research Site 1007, Boise, Idaho, United States
- Research Site 1048, Glenview, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06598462 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Eosinophilic esophagitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07112378A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic EsophagitisRegeneron Pharmaceuticals
- RECRUITINGNCT07156357Surface EMG Testing on Swallowing in EoE PatientsMayo Clinic
- RECRUITINGNCT07012928Local Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier Function and Type II InflammationAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- RECRUITINGNCT06972147Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic EsophagitisUniversity Hospital, Angers
- RECRUITINGPHASE2NCT05485155Zemaira Eosinophilic Esophagitis Pilot StudyChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06756581Tolerability of Baked Dairy Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein TriggerShaare Zedek Medical Center
- RECRUITINGPHASE2NCT06705387Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoEUniversity of Colorado, Denver
- RECRUITINGNCT06693531A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareRegeneron Pharmaceuticals
See all trials for NON RARE IN EUROPE: Eosinophilic esophagitis →